Federal contractor · WATERTOWN, MA

FLUENT BIOSCIENCES INC

No contract obligations recorded for FLUENT BIOSCIENCES INC in FY2026. Since FY2023: $95.5K.

Obligations · FY2026
$0
New awards
0
Sole-source
—
Single offer
—
UEI
DA7UPTVQMG73
Parent company
FLUENT BIOSCIENCES INC
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 14.1KFY2023
  2. 81.4KFY2024

Top buying agencies

Obligations in FY2026.

No contract obligations recorded for FLUENT BIOSCIENCES INC in FY2026.

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

FLUENT BIOSCIENCES INC received $0 in federal assistance in FY2026, on 0 actions (0 new awards).

Assistance · FY2026
$0
New awards
0
Actions
0
Since FY2021
$3.5M

Assistance by fiscal year

  1. 825.6KFY2021
  2. 903.7KFY2022
  3. 1.9MFY2023
  4. -2.6KFY2024
  5. -180.6KFY2025

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2021–FY2025.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. AFFINITY RESEARCH CHEMICALS INC$80.3K
    WILMINGTON, DE · 99% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. FUJIREBIO US, INC.$85.9K−100% in FY2026
    MALVERN, PA · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. US SPECIALTY FORMULATIONS LLC$71.9K−100% in FY2026
    ALLENTOWN, PA · 88% of this company's obligations are in markets they both serveNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 7, 2026, loaded Oct 7, 2026.